Verinetics Announces Collaboration with CHESS Health to Support Methadone Treatment for Opioid … | news

Research Triangle Park, NC and Rochester, NY, April 18, 2022 (GLOBE NEWSWIRE) — Verinetics, the developer of DispenSecur™ designed to help expand access to medications to treat Opioid Use Disorder (OUD) and Phase II SBIR contract awardee from the National Institutes of Health’s National Institute on Drug Abuse (NIDA) – today announced a collaboration with …

Verinetics Announces Collaboration with CHESS Health to Support Methadone Treatment for Opioid … | news Read More »